<DOC>
	<DOCNO>NCT03047291</DOCNO>
	<brief_summary>Evaluate clinically microbiologically effect oral probiotic Lactobacillus reuteri Prodentis ( PerioBalance® , Sunstar , Switzerland ) implant mucositis periimplantitis , coadjuvant treatment mechanical therapy .</brief_summary>
	<brief_title>Effect Probiotic Lactobacillus Reuteri Treatment Mucositis Periimplantitis</brief_title>
	<detailed_description>A total 44 patient , 22 mucositis 22 periimplantitis , randomly assign either control test group , 11 patient receive placebo 11 probiotic treatment . After baseline clinical , radiological microbiological examination , study group randomly assign ( probiotic placebo ) , supragingival prophylaxis perform mucositis group subgingival mechanical therapy periimplantitis group . Then get container 30 probiotic placebo tablet instruction take . At 30 90 day begin treatment , clinical , radiological microbiological examination perform .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Peri-Implantitis</mesh_term>
	<criteria>adult patient general good health , nonsmoker , history mild moderate chronic periodontitis least one dental implant probe pocket depth ≥4mm together bleed probe and/or suppuration , fix prosthetic restoration function least 12 month , compliance periodontal maintenance program , accessibility study period receptiveness ability fulfill protocol . pregnant lactate woman , patient require prophylaxis bacterial endocarditis take local systemic antibiotic , antiinflammatory , antiseptic probiotic therapy previous 3 month , subject receive surgical periodontal treatment last 6 month , uncontrolled periodontal disease , previous current history alcoholism smoking , treatment bisphosphonates , neurologic deficiency , systemic disease immunodeficiency uncontrolled diabetes , rheumatoid , hepatic , renal , cardiovascular infectious pathology , radiotherapy , chemotherapy , use medication affect periodontal level , lack patient cooperation ( failure follow treatment instruction and/or failure attend visit ) , implant mobility and/or radiographic bone loss ≥ 5mm and/or ≥ 50 % implant length .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>mucositis , periimplantitis , probiotic</keyword>
</DOC>